Zobrazeno 1 - 10
of 1 036
pro vyhledávání: '"Abuse deterrent"'
Autor:
Bhola J; Department of Pharmaceutics, Gujarat Technological University, Ahmedabad, India., Borkhataria C; Department of Pharmaceutics, B. K. Mody Government Pharmacy College, Rajkot, India.
Publikováno v:
Pharmaceutical development and technology [Pharm Dev Technol] 2024 Oct; Vol. 29 (8), pp. 824-831. Date of Electronic Publication: 2024 Sep 03.
Autor:
Ram Munnangi S; Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, University, MS, 38677; Pii Center for Pharmaceutical Technology, The University of Mississippi, University, MS 38677, USA., Narala N; Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, University, MS, 38677., Lakkala P; Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, University, MS, 38677., Kumar Vemula S; Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, University, MS, 38677., Repka M; Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, University, MS, 38677; Pii Center for Pharmaceutical Technology, The University of Mississippi, University, MS 38677, USA. Electronic address: marepka@olemiss.edu.
Publikováno v:
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2024 Apr; Vol. 197, pp. 114230. Date of Electronic Publication: 2024 Feb 17.
Autor:
DiPrete BL; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA.; Injury Prevention Research Center, University of North Carolina, Chapel Hill, North Carolina, USA., Oh G; Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, Lexington, Kentucky, USA.; Institute for Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Kentucky, Lexington, Kentucky, USA.; Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.; Department of Epidemiology and Environmental Health, University of Kentucky, Lexington, Kentucky, USA., Moga DC; Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, Lexington, Kentucky, USA.; Institute for Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Kentucky, Lexington, Kentucky, USA.; Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.; Department of Epidemiology and Environmental Health, University of Kentucky, Lexington, Kentucky, USA., Dasgupta N; Injury Prevention Research Center, University of North Carolina, Chapel Hill, North Carolina, USA., Slavova S; Department of Biostatistics, University of Kentucky College of Public Health, Lexington, Kentucky, USA., Slade E; Department of Biostatistics, University of Kentucky College of Public Health, Lexington, Kentucky, USA., Delcher C; Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, Lexington, Kentucky, USA.; Institute for Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Kentucky, Lexington, Kentucky, USA., Pence BW; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA., Ranapurwala SI; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA.; Injury Prevention Research Center, University of North Carolina, Chapel Hill, North Carolina, USA.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 May; Vol. 33 (5), pp. e5805.
Autor:
Qu H; Division of Product Quality Research, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20993. Electronic address: Haiou.Qu@fda.hhs.gov., Smith WC; Division of Product Quality Research, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20993., Feng X; Division of Product Quality Research, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20993., Wang J; Division of Product Quality Research, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20993., Pinto J; Division of New Drug Product II, Office of New Drug Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research U.S. Food and Drug Administration, Silver Spring, Maryland 20993., Xu X; Division of Product Quality Research, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20993., Faustino PJ; Division of Product Quality Research, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20993. Electronic address: Patrick.Faustino@fda.hhs.gov.
Publikováno v:
Journal of chromatography. A [J Chromatogr A] 2023 Aug 30; Vol. 1705, pp. 464186. Date of Electronic Publication: 2023 Jun 29.
Autor:
Gad SF; Department of Industrial and Molecular Pharmaceutics, Purdue University, 575 West Stadium Avenue, West Lafayette, IN 47907, USA; Department of Pharmaceutics, Faculty of Pharmacy, Assiut University, Assiut, Egypt., Vasiukhina A; Weldon School of Biomedical Engineering, Purdue University, 206 S Martin Jischke Dr., West Lafayette, IN 47907, USA., Keller JS; Department of Chemistry, Purdue University, 560 Oval Dr, West Lafayette, IN 47907, USA., Solorio L; Weldon School of Biomedical Engineering, Purdue University, 206 S Martin Jischke Dr., West Lafayette, IN 47907, USA., Yeo Y; Department of Industrial and Molecular Pharmaceutics, Purdue University, 575 West Stadium Avenue, West Lafayette, IN 47907, USA; Weldon School of Biomedical Engineering, Purdue University, 206 S Martin Jischke Dr., West Lafayette, IN 47907, USA. Electronic address: yyeo@purdue.edu.
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2024 Jun; Vol. 370, pp. 490-500. Date of Electronic Publication: 2024 May 08.
Autor:
Jewell J; Rocky Mountain Poison and Drug Safety, Denver Health and Hospital Authority, 1391 Speer Blvd UNIT 600, Denver, CO, 80204, USA. Jennifer.jewell@rmpds.org., Black J; Rocky Mountain Poison and Drug Safety, Denver Health and Hospital Authority, 1391 Speer Blvd UNIT 600, Denver, CO, 80204, USA., Ellis M; Department of Psychiatry, School of Medicine, Washington University in St. Louis, 660 S Euclid Ave, St. Louis, MO, 63110, USA., Olsen H; Rocky Mountain Poison and Drug Safety, Denver Health and Hospital Authority, 1391 Speer Blvd UNIT 600, Denver, CO, 80204, USA., Iwanicki J; Rocky Mountain Poison and Drug Safety, Denver Health and Hospital Authority, 1391 Speer Blvd UNIT 600, Denver, CO, 80204, USA., Dart R; Rocky Mountain Poison and Drug Safety, Denver Health and Hospital Authority, 1391 Speer Blvd UNIT 600, Denver, CO, 80204, USA.
Publikováno v:
Clinical drug investigation [Clin Drug Investig] 2023 Mar; Vol. 43 (3), pp. 197-203. Date of Electronic Publication: 2023 Mar 01.
Autor:
Zhang X; Division of Behavioral Neuropharmacology, International Center for Brain Science (ICBS), Fujita Health University, Toyoake, 470-1192, Aichi, Japan., Kitaichi K; Laboratory of Pharmaceutics, Department of Biomedical Pharmaceutics, Gifu Pharmaceutical University, Gifu, 501-1196, Gifu, Japan., Mouri A; Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices, Graduate School of Health Sciences, Fujita Health University, Toyoake, 470-1192, Aichi, Japan; Japanese Drug Organization of Appropriate Use and Research, Nagoya, 468-0069, Aichi, Japan., Zhou X; Division of Behavioral Neuropharmacology, International Center for Brain Science (ICBS), Fujita Health University, Toyoake, 470-1192, Aichi, Japan., Nabeshima T; Japanese Drug Organization of Appropriate Use and Research, Nagoya, 468-0069, Aichi, Japan; Laboratory of Health and Medical Science Innovation, Graduate School of Health Sciences, Fujita Health University, Toyoake, 470-1192, Aichi, Japan., Yamada K; Japanese Drug Organization of Appropriate Use and Research, Nagoya, 468-0069, Aichi, Japan; Department of Neuropsychopharmacology and Hospital Pharmacy, Graduate School of Medicine, Nagoya University, Nagoya, 466-8560, Aichi, Japan., Nagai T; Division of Behavioral Neuropharmacology, International Center for Brain Science (ICBS), Fujita Health University, Toyoake, 470-1192, Aichi, Japan. Electronic address: taku.nagai@fujita-hu.ac.jp.
Publikováno v:
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2023 Jan 08; Vol. 639, pp. 100-105. Date of Electronic Publication: 2022 Nov 30.
Autor:
Kibria G; Division of Product Quality and Research, Office of Testing and Research, Center for Drug Evaluation and Research, Food and Drug Administration, MD, United States. Electronic address: golam.kibria@fda.hhs.gov., Bandaranayake B; Division of Product Quality and Research, Office of Testing and Research, Center for Drug Evaluation and Research, Food and Drug Administration, MD, United States., Zheng J; Division of Biology, Chemistry and Materials Science, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, Food and Drug Administration, MD, United States., Lee S; Division of Product Quality and Research, Office of Testing and Research, Center for Drug Evaluation and Research, Food and Drug Administration, MD, United States., Cruz C; Division of Product Quality and Research, Office of Testing and Research, Center for Drug Evaluation and Research, Food and Drug Administration, MD, United States; Currently at Eli Lilly and Company, United States.
Publikováno v:
International journal of pharmaceutics [Int J Pharm] 2023 Jan 25; Vol. 631, pp. 122430. Date of Electronic Publication: 2022 Dec 07.
Autor:
Vasiukhina A; Weldon School of Biomedical Engineering, Purdue University, West Lafayette, IN 47907, USA., Gad SF; Department of Industrial and Physical Pharmacy, Purdue University, West Lafayette, IN 47907, USA; Department of Pharmaceutics, Faculty of Pharmacy, Assiut University, Assiut, Egypt., Wellington EN; Weldon School of Biomedical Engineering, Purdue University, West Lafayette, IN 47907, USA., Wilmes DM; Weldon School of Biomedical Engineering, Purdue University, West Lafayette, IN 47907, USA., Yeo Y; Weldon School of Biomedical Engineering, Purdue University, West Lafayette, IN 47907, USA; Department of Industrial and Physical Pharmacy, Purdue University, West Lafayette, IN 47907, USA., Solorio L; Weldon School of Biomedical Engineering, Purdue University, West Lafayette, IN 47907, USA; Center for Cancer Research, Purdue University, West Lafayette, IN 47907, USA.
Publikováno v:
International journal of pharmaceutics [Int J Pharm] 2022 Oct 15; Vol. 626, pp. 122151. Date of Electronic Publication: 2022 Aug 28.
Autor:
Palekar S; College of Pharmacy and Health Sciences, St. John's University, Queens, NY, USA., Nukala PK; College of Pharmacy and Health Sciences, St. John's University, Queens, NY, USA; Teva Pharmaceuticals, Weston, FL, USA., Patel K; College of Pharmacy and Health Sciences, St. John's University, Queens, NY, USA. Electronic address: patelk2@stjohns.edu.
Publikováno v:
International journal of pharmaceutics [Int J Pharm] 2022 Jun 10; Vol. 621, pp. 121804. Date of Electronic Publication: 2022 May 06.